首页 > 最新文献

Extracellular vesicles and circulating nucleic acids最新文献

英文 中文
Flow cytometry for extracellular vesicle characterization in COVID-19 and post-acute sequelae of SARS-CoV-2 infection 用流式细胞术鉴定 COVID-19 和 SARS-CoV-2 感染急性后遗症中细胞外囊泡的特征
Pub Date : 2024-08-09 DOI: 10.20517/evcna.2024.20
Marialaura Fanelli, Vita Petrone, Rossella Chirico, Claudia Maria Radu, A. Minutolo, Claudia Matteucci
Infection with SARS-CoV-2, the virus responsible for COVID-19 diseases, can impact different tissues and induce significant cellular alterations. The production of extracellular vesicles (EVs), which are physiologically involved in cell communication, is also altered during COVID-19, along with the dysfunction of cytoplasmic organelles. Since circulating EVs reflect the state of their cells of origin, they represent valuable tools for monitoring pathological conditions. Despite challenges in detecting EVs due to their size and specific cellular compartment origin using different methodologies, flow cytometry has proven to be an effective method for assessing the role of EVs in COVID-19. This review summarizes the involvement of plasmatic EVs in COVID-19 patients and individuals with Long COVID (LC) affected by post-acute sequelae of SARS-CoV-2 infection (PASC), highlighting their dual role in exerting both pro- and antiviral effects. We also emphasize how flow cytometry, with its multiparametric approach, can be employed to characterize circulating EVs, particularly in infectious diseases such as COVID-19, and suggest their potential role in chronic impairments during post-infection.
感染 SARS-CoV-2(导致 COVID-19 疾病的病毒)会影响不同的组织,并诱发重大的细胞变化。在 COVID-19 期间,细胞外囊泡 (EV) 的产生也会发生改变,细胞质细胞器的功能也会失调。由于循环中的EV反映了其来源细胞的状态,因此它们是监测病理状况的重要工具。尽管由于EVs的大小和特定的细胞区系来源,使用不同的方法检测EVs存在挑战,但流式细胞术已被证明是评估EVs在COVID-19中作用的有效方法。本综述总结了COVID-19患者和受SARS-CoV-2感染急性后遗症(PASC)影响的长COVID(LC)患者体内浆细胞EVs的参与情况,强调了它们在发挥促病毒和抗病毒作用方面的双重作用。我们还强调了流式细胞术及其多参数方法如何用于描述循环 EVs 的特征,特别是在 COVID-19 等传染性疾病中,并提出了它们在感染后慢性损伤中的潜在作用。
{"title":"Flow cytometry for extracellular vesicle characterization in COVID-19 and post-acute sequelae of SARS-CoV-2 infection","authors":"Marialaura Fanelli, Vita Petrone, Rossella Chirico, Claudia Maria Radu, A. Minutolo, Claudia Matteucci","doi":"10.20517/evcna.2024.20","DOIUrl":"https://doi.org/10.20517/evcna.2024.20","url":null,"abstract":"Infection with SARS-CoV-2, the virus responsible for COVID-19 diseases, can impact different tissues and induce significant cellular alterations. The production of extracellular vesicles (EVs), which are physiologically involved in cell communication, is also altered during COVID-19, along with the dysfunction of cytoplasmic organelles. Since circulating EVs reflect the state of their cells of origin, they represent valuable tools for monitoring pathological conditions. Despite challenges in detecting EVs due to their size and specific cellular compartment origin using different methodologies, flow cytometry has proven to be an effective method for assessing the role of EVs in COVID-19. This review summarizes the involvement of plasmatic EVs in COVID-19 patients and individuals with Long COVID (LC) affected by post-acute sequelae of SARS-CoV-2 infection (PASC), highlighting their dual role in exerting both pro- and antiviral effects. We also emphasize how flow cytometry, with its multiparametric approach, can be employed to characterize circulating EVs, particularly in infectious diseases such as COVID-19, and suggest their potential role in chronic impairments during post-infection.","PeriodicalId":73008,"journal":{"name":"Extracellular vesicles and circulating nucleic acids","volume":"71 14","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141922498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extracellular vesicles in tumor-adipose tissue crosstalk: key drivers and therapeutic targets in cancer cachexia 肿瘤-脂肪组织串联过程中的细胞外囊泡:癌症恶病质的关键驱动因素和治疗靶点
Pub Date : 2024-07-23 DOI: 10.20517/evcna.2024.36
Cátia C Ramos, José Pires, Esperanza González, C. Garcia-Vallicrosa, Celso A. Reis, J. Falcón-Perez, D. Freitas
Cancer cachexia is a complex metabolic syndrome characterized by unintentional loss of skeletal muscle and body fat. This syndrome is frequently associated with different types of cancer and negatively affects the prognosis and outcome of these patients. It involves a dynamic interplay between tumor cells and adipose tissue, where tumor-derived extracellular vesicles (EVs) play a crucial role in mediating intercellular communication. Tumor cells release EVs containing bioactive molecules such as hormones (adrenomedullin, PTHrP), pro-inflammatory cytokines (IL-6), and miRNAs (miR-1304-3p, miR-204-5p, miR-155, miR-425-3p, miR-146b-5p, miR-92a-3p), which can trigger lipolysis and induce the browning of white adipocytes contributing to a cancer cachexia phenotype. On the other hand, adipocyte-derived EVs can reprogram the metabolism of tumor cells by transporting fatty acids and enzymes involved in fatty acid oxidation, resulting in tumor growth and progression. These vesicles also carry leptin and key miRNAs (miR-155-5p, miR-10a-3p, miR-30a-3p, miR-32a/b, miR-21), thereby supporting tumor cell proliferation, metastasis formation, and therapy resistance. Understanding the intricate network underlying EV-mediated communication between tumor cells and adipocytes can provide critical insights into the mechanisms driving cancer cachexia. This review consolidates current knowledge on the crosstalk between tumor cells and adipose tissue mediated by EVs and offers valuable insights for future research. It also addresses controversial topics in the field and possible therapeutic approaches to manage cancer cachexia and ultimately improve patient outcomes and quality of life.
癌症恶病质是一种复杂的代谢综合征,其特点是骨骼肌和身体脂肪的无意损失。这种综合征经常与不同类型的癌症有关,并对这些患者的预后和疗效产生负面影响。它涉及肿瘤细胞和脂肪组织之间的动态相互作用,其中肿瘤衍生的细胞外囊泡 (EVs) 在介导细胞间交流方面发挥着至关重要的作用。肿瘤细胞释放的细胞外囊泡含有生物活性分子,如激素(肾上腺髓质素、PTHrP)、促炎细胞因子(IL-6)和 miRNA(miR-1304-3p、miR-204-5p、miR-155、miR-425-3p、miR-146b-5p、miR-92a-3p),这些分子可引发脂肪分解,诱导白色脂肪细胞褐变,从而形成癌症恶病质表型。另一方面,脂肪细胞衍生的 EVs 可通过运输脂肪酸和参与脂肪酸氧化的酶来重编程肿瘤细胞的新陈代谢,从而导致肿瘤的生长和进展。这些囊泡还携带瘦素和关键的 miRNA(miR-155-5p、miR-10a-3p、miR-30a-3p、miR-32a/b、miR-21),从而支持肿瘤细胞的增殖、转移和耐药性。了解肿瘤细胞和脂肪细胞之间由 EV 介导的错综复杂的交流网络,能为了解癌症恶病质的驱动机制提供重要见解。这篇综述整合了目前关于由 EVs 介导的肿瘤细胞与脂肪组织之间串联的知识,并为未来研究提供了宝贵的见解。它还探讨了该领域存在争议的话题,以及控制癌症恶病质并最终改善患者预后和生活质量的可能治疗方法。
{"title":"Extracellular vesicles in tumor-adipose tissue crosstalk: key drivers and therapeutic targets in cancer cachexia","authors":"Cátia C Ramos, José Pires, Esperanza González, C. Garcia-Vallicrosa, Celso A. Reis, J. Falcón-Perez, D. Freitas","doi":"10.20517/evcna.2024.36","DOIUrl":"https://doi.org/10.20517/evcna.2024.36","url":null,"abstract":"Cancer cachexia is a complex metabolic syndrome characterized by unintentional loss of skeletal muscle and body fat. This syndrome is frequently associated with different types of cancer and negatively affects the prognosis and outcome of these patients. It involves a dynamic interplay between tumor cells and adipose tissue, where tumor-derived extracellular vesicles (EVs) play a crucial role in mediating intercellular communication. Tumor cells release EVs containing bioactive molecules such as hormones (adrenomedullin, PTHrP), pro-inflammatory cytokines (IL-6), and miRNAs (miR-1304-3p, miR-204-5p, miR-155, miR-425-3p, miR-146b-5p, miR-92a-3p), which can trigger lipolysis and induce the browning of white adipocytes contributing to a cancer cachexia phenotype. On the other hand, adipocyte-derived EVs can reprogram the metabolism of tumor cells by transporting fatty acids and enzymes involved in fatty acid oxidation, resulting in tumor growth and progression. These vesicles also carry leptin and key miRNAs (miR-155-5p, miR-10a-3p, miR-30a-3p, miR-32a/b, miR-21), thereby supporting tumor cell proliferation, metastasis formation, and therapy resistance. Understanding the intricate network underlying EV-mediated communication between tumor cells and adipocytes can provide critical insights into the mechanisms driving cancer cachexia. This review consolidates current knowledge on the crosstalk between tumor cells and adipose tissue mediated by EVs and offers valuable insights for future research. It also addresses controversial topics in the field and possible therapeutic approaches to manage cancer cachexia and ultimately improve patient outcomes and quality of life.","PeriodicalId":73008,"journal":{"name":"Extracellular vesicles and circulating nucleic acids","volume":"143 16","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141810833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Harnessing crosstalk between extracellular vesicles and viruses for disease diagnostics and therapeutics 利用细胞外囊泡和病毒之间的串扰进行疾病诊断和治疗
Pub Date : 2024-07-07 DOI: 10.20517/evcna.2024.30
Xinxi Zhu, Xiuhui Lin, Liang Hu, Liangxing Wang, Qingfu Zhu
Extracellular vesicles (EVs) are increasingly acknowledged as important mediators of intercellular communication, closely related to the occurrence and development of a variety of diseases. Numerous studies have demonstrated that EVs play a multifaceted role in the infection process of viral diseases, elucidating their ability to both facilitate viral spread and inhibit infection progression. These versatile entities not only enhance infection rates and widen the scope of viral infection through the transmission of entire viruses or viral genomes, but also trigger antiviral responses and prompt cytokine secretion near the infection site, thereby fortifying the host's defense mechanisms and safeguarding neighboring cells against infection. This complicated crosstalk between EVs and viral infections prompts a deeper exploration into their roles in potential clinical applications. In this review, we aim to encapsulate the recent advances in understanding the intricate interplay between viruses and EVs, shedding light on the mechanisms underlying this vesicle-to-virion crosstalk. Furthermore, we underscore the significance of harnessing this knowledge for diagnostic and therapeutic functions in combating viral diseases.
人们日益认识到,细胞外囊泡(EVs)是细胞间通信的重要媒介,与多种疾病的发生和发展密切相关。大量研究表明,EVs 在病毒性疾病的感染过程中发挥着多方面的作用,阐明了它们既能促进病毒传播又能抑制感染进展的能力。这些多用途实体不仅能通过传播整个病毒或病毒基因组来提高感染率和扩大病毒感染范围,还能触发感染部位附近的抗病毒反应并促使细胞因子分泌,从而强化宿主的防御机制并保护邻近细胞免受感染。EVs 与病毒感染之间的这种复杂串扰促使人们深入探讨 EVs 在潜在临床应用中的作用。在这篇综述中,我们旨在概括了解病毒与 EVs 之间错综复杂的相互作用的最新进展,揭示囊泡与病毒之间串扰的内在机制。此外,我们还强调了利用这些知识来诊断和治疗病毒性疾病的重要意义。
{"title":"Harnessing crosstalk between extracellular vesicles and viruses for disease diagnostics and therapeutics","authors":"Xinxi Zhu, Xiuhui Lin, Liang Hu, Liangxing Wang, Qingfu Zhu","doi":"10.20517/evcna.2024.30","DOIUrl":"https://doi.org/10.20517/evcna.2024.30","url":null,"abstract":"Extracellular vesicles (EVs) are increasingly acknowledged as important mediators of intercellular communication, closely related to the occurrence and development of a variety of diseases. Numerous studies have demonstrated that EVs play a multifaceted role in the infection process of viral diseases, elucidating their ability to both facilitate viral spread and inhibit infection progression. These versatile entities not only enhance infection rates and widen the scope of viral infection through the transmission of entire viruses or viral genomes, but also trigger antiviral responses and prompt cytokine secretion near the infection site, thereby fortifying the host's defense mechanisms and safeguarding neighboring cells against infection. This complicated crosstalk between EVs and viral infections prompts a deeper exploration into their roles in potential clinical applications. In this review, we aim to encapsulate the recent advances in understanding the intricate interplay between viruses and EVs, shedding light on the mechanisms underlying this vesicle-to-virion crosstalk. Furthermore, we underscore the significance of harnessing this knowledge for diagnostic and therapeutic functions in combating viral diseases.","PeriodicalId":73008,"journal":{"name":"Extracellular vesicles and circulating nucleic acids","volume":" 17","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141670138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endosomal escape mechanisms of extracellular vesicle-based drug carriers: lessons for lipid nanoparticle design 基于细胞外囊泡的药物载体的内泌体逃逸机制:脂质纳米粒子设计的启示
Pub Date : 2024-07-05 DOI: 10.20517/evcna.2024.19
Lasse Hagedorn, David C. Jürgens, Olivia M. Merkel, Benjamin Winkeljann
The rise of biologics and RNA-based therapies challenges the limitations of traditional drug treatments. However, these potent new classes of therapeutics require effective delivery systems to reach their full potential. Lipid nanoparticles (LNPs) have emerged as a promising solution for RNA delivery, but endosomal entrapment remains a critical barrier. In contrast, natural extracellular vesicles (EVs) possess innate mechanisms to overcome endosomal degradation, demonstrating superior endosomal escape (EE) compared to conventional LNPs. This mini review explores the challenges of EE for lipid nanoparticle-based drug delivery, and offers insights into EV escape mechanisms to advance LNP design for RNA therapeutics. We compare the natural EE strategies of EVs with those used in LNPs and highlight contemporary LNP design approaches. By understanding the mechanisms of EE, we will be able to develop more effective drug delivery vehicles, enhancing the delivery and efficacy of RNA-based therapies.
生物制剂和基于 RNA 的疗法的兴起挑战了传统药物治疗的局限性。然而,这些强效的新型疗法需要有效的递送系统才能充分发挥其潜力。脂质纳米颗粒(LNPs)已成为一种很有前景的 RNA 递送解决方案,但其内贮器禁锢仍是一个关键障碍。相比之下,天然细胞外囊泡(EVs)具有克服内体降解的内在机制,与传统的 LNPs 相比,EVs 表现出更优越的内体逃逸(EE)能力。这篇微型综述探讨了基于脂质纳米粒子的药物递送所面临的EE挑战,并深入探讨了EV的逃逸机制,从而推动了用于RNA治疗的LNP设计。我们将 EV 的天然 EE 策略与 LNP 中使用的 EE 策略进行了比较,并重点介绍了当代的 LNP 设计方法。通过了解 EE 的机制,我们将能开发出更有效的药物递送载体,提高基于 RNA 的疗法的递送和疗效。
{"title":"Endosomal escape mechanisms of extracellular vesicle-based drug carriers: lessons for lipid nanoparticle design","authors":"Lasse Hagedorn, David C. Jürgens, Olivia M. Merkel, Benjamin Winkeljann","doi":"10.20517/evcna.2024.19","DOIUrl":"https://doi.org/10.20517/evcna.2024.19","url":null,"abstract":"The rise of biologics and RNA-based therapies challenges the limitations of traditional drug treatments. However, these potent new classes of therapeutics require effective delivery systems to reach their full potential. Lipid nanoparticles (LNPs) have emerged as a promising solution for RNA delivery, but endosomal entrapment remains a critical barrier. In contrast, natural extracellular vesicles (EVs) possess innate mechanisms to overcome endosomal degradation, demonstrating superior endosomal escape (EE) compared to conventional LNPs. This mini review explores the challenges of EE for lipid nanoparticle-based drug delivery, and offers insights into EV escape mechanisms to advance LNP design for RNA therapeutics. We compare the natural EE strategies of EVs with those used in LNPs and highlight contemporary LNP design approaches. By understanding the mechanisms of EE, we will be able to develop more effective drug delivery vehicles, enhancing the delivery and efficacy of RNA-based therapies.","PeriodicalId":73008,"journal":{"name":"Extracellular vesicles and circulating nucleic acids","volume":" 22","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141675869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synovial fluid extracellular vesicles as arthritis biomarkers: the added value of lipid-profiling and integrated omics 作为关节炎生物标记物的滑膜液细胞外囊泡:脂质分析和综合全息技术的附加值
Pub Date : 2024-06-13 DOI: 10.20517/evcna.2024.14
L. Varela, Chris H.A. van de Lest, P. V. van Weeren, M. Wauben
Arthritis, a diverse group of inflammatory joint disorders, poses great challenges in early diagnosis and targeted treatment. Timely intervention is imperative, yet conventional diagnostic methods are not able to detect subtle early symptoms. Hence, there is an urgent need for specific biomarkers that discriminate between different arthritis forms and for early diagnosis. The pursuit of such precise diagnostic tools has prompted a growing interest in extracellular vesicles (EVs). EVs, released by cells in a regulated fashion, are detectable in body fluids, including synovial fluid (SF), which fills the joint space. They provide insights into the intricate molecular landscapes of arthritis, and this has stimulated the search for minimally invasive EV-based diagnostics. As such, the analysis of EVs in SF has become a focus for identifying EV-based biomarkers for joint disease endotyping, prognosis, and progression. EVs are composed of a lipid bilayer and a wide variety of different cargo types, of which proteins and RNAs are widely investigated. In contrast, membrane lipids of EVs, especially the abundance, presence, or absence of specific lipids and their contribution to the biological activity of EVs, are largely overlooked in EV research. Furthermore, the identification of specific combinations of different EV components acting in concert in EVs can fuel the definition of composite biomarkers. We here provide a state-of-the-art overview of the knowledge on SF-derived EVs with emphasis on lipid analysis and we give an example of the added value of integrated proteomics and lipidomics analysis in the search for composite EV-associated biomarkers.
关节炎是一种多种多样的关节炎性疾病,给早期诊断和针对性治疗带来了巨大挑战。及时干预势在必行,但传统的诊断方法无法检测出细微的早期症状。因此,我们迫切需要能区分不同关节炎类型并进行早期诊断的特异性生物标志物。对这种精确诊断工具的追求促使人们对细胞外囊泡 (EV) 的兴趣与日俱增。细胞外囊泡由细胞以调节方式释放,可在体液中检测到,包括填充关节间隙的滑液(SF)。它们能让人了解关节炎错综复杂的分子结构,这也刺激了人们寻找基于 EV 的微创诊断方法。因此,分析 SF 中的 EVs 已成为确定基于 EV 的关节疾病内分型、预后和进展生物标志物的重点。EVs 由脂质双分子层和多种不同类型的货物组成,其中蛋白质和 RNA 已被广泛研究。相比之下,EVs 的膜脂质,尤其是特定脂质的丰度、存在或不存在及其对 EVs 生物活性的贡献,在 EVs 研究中大多被忽视。此外,鉴定EVs中协同作用的不同EV成分的特定组合有助于定义复合生物标志物。我们在此概述了有关 SF 衍生 EV 的最新知识,重点是脂质分析,并举例说明了蛋白质组学和脂质组学综合分析在寻找 EV 相关复合生物标记物方面的附加值。
{"title":"Synovial fluid extracellular vesicles as arthritis biomarkers: the added value of lipid-profiling and integrated omics","authors":"L. Varela, Chris H.A. van de Lest, P. V. van Weeren, M. Wauben","doi":"10.20517/evcna.2024.14","DOIUrl":"https://doi.org/10.20517/evcna.2024.14","url":null,"abstract":"Arthritis, a diverse group of inflammatory joint disorders, poses great challenges in early diagnosis and targeted treatment. Timely intervention is imperative, yet conventional diagnostic methods are not able to detect subtle early symptoms. Hence, there is an urgent need for specific biomarkers that discriminate between different arthritis forms and for early diagnosis. The pursuit of such precise diagnostic tools has prompted a growing interest in extracellular vesicles (EVs). EVs, released by cells in a regulated fashion, are detectable in body fluids, including synovial fluid (SF), which fills the joint space. They provide insights into the intricate molecular landscapes of arthritis, and this has stimulated the search for minimally invasive EV-based diagnostics. As such, the analysis of EVs in SF has become a focus for identifying EV-based biomarkers for joint disease endotyping, prognosis, and progression. EVs are composed of a lipid bilayer and a wide variety of different cargo types, of which proteins and RNAs are widely investigated. In contrast, membrane lipids of EVs, especially the abundance, presence, or absence of specific lipids and their contribution to the biological activity of EVs, are largely overlooked in EV research. Furthermore, the identification of specific combinations of different EV components acting in concert in EVs can fuel the definition of composite biomarkers. We here provide a state-of-the-art overview of the knowledge on SF-derived EVs with emphasis on lipid analysis and we give an example of the added value of integrated proteomics and lipidomics analysis in the search for composite EV-associated biomarkers.","PeriodicalId":73008,"journal":{"name":"Extracellular vesicles and circulating nucleic acids","volume":"51 30","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141345016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitochondria-derived vesicles: potential nano-batteries to recharge the cellular powerhouse. 线粒体衍生囊泡:为细胞动力室充电的潜在纳米电池。
Pub Date : 2024-06-01 Epub Date: 2024-06-10 DOI: 10.20517/evcna.2023.71
Shalini Mishra, Gagan Deep

Mitochondria dysfunction is increasingly recognized as a critical factor in various pathogenic processes. The mechanism governing mitochondrial quality control serves as an adaptive response, ensuring the preservation of mitochondrial morphology, quantity, and overall function, crucial for cell survival. The generation of mitochondria-derived vesicles (MDVs) is one of the processes of mitochondrial quality control. Recent literature has suggested MDV heterogeneity; however, the detailed characteristics of various MDV subtypes still need to be studied better. Recent studies have shown that MDVs also play a role in inter-organelle communication for mitochondria besides quality control. For instance, Hazan et al. demonstrated that functional mitochondria from Saccharomyces cerevisiae release vesicles independent of the fission machinery. These vesicles, falling within the typical size range of MDVs, were selectively loaded with mitochondrial proteins, especially with functional ATP synthase subunits. Intriguingly, these MDVs maintained membrane potential and could generate ATP. Moreover, MDVs could fuse with naïve mitochondria, transferring their ATP generation machinery. Lastly, this study revealed a potential delivery mechanism of ATP-producing vesicles, presenting a promising avenue to rejuvenate ATP-deficient mitochondria. Overall, this study unveils a novel mechanism for inter-organelle communication by vesicles, which is crucial for maintaining cellular homeostasis and could also be important in pathological conditions.

线粒体功能障碍越来越被认为是各种致病过程的关键因素。线粒体质量控制机制是一种适应性反应,可确保线粒体形态、数量和整体功能的保持,这对细胞存活至关重要。线粒体衍生囊泡(MDV)的生成是线粒体质量控制的过程之一。最近的文献表明 MDV 具有异质性,但各种 MDV 亚型的详细特征仍有待进一步研究。最近的研究表明,除了质量控制外,MDV 还在线粒体的细胞器间通讯中发挥作用。例如,Hazan 等人证实,酿酒酵母的功能线粒体会释放独立于裂变机制的囊泡。这些囊泡属于 MDV 的典型大小范围,选择性地装载了线粒体蛋白质,尤其是功能性 ATP 合成酶亚基。有趣的是,这些 MDVs 能保持膜电位并产生 ATP。此外,MDVs 还能与幼稚线粒体融合,转移其 ATP 生成机制。最后,这项研究揭示了产生 ATP 的囊泡的潜在传递机制,为 ATP 缺乏的线粒体的恢复提供了一条有希望的途径。总之,这项研究揭示了小泡进行细胞器间通讯的新机制,这种机制对维持细胞平衡至关重要,在病理情况下也很重要。
{"title":"Mitochondria-derived vesicles: potential nano-batteries to recharge the cellular powerhouse.","authors":"Shalini Mishra, Gagan Deep","doi":"10.20517/evcna.2023.71","DOIUrl":"10.20517/evcna.2023.71","url":null,"abstract":"<p><p>Mitochondria dysfunction is increasingly recognized as a critical factor in various pathogenic processes. The mechanism governing mitochondrial quality control serves as an adaptive response, ensuring the preservation of mitochondrial morphology, quantity, and overall function, crucial for cell survival. The generation of mitochondria-derived vesicles (MDVs) is one of the processes of mitochondrial quality control. Recent literature has suggested MDV heterogeneity; however, the detailed characteristics of various MDV subtypes still need to be studied better. Recent studies have shown that MDVs also play a role in inter-organelle communication for mitochondria besides quality control. For instance, Hazan <i>et al.</i> demonstrated that functional mitochondria from <i>Saccharomyces cerevisiae</i> release vesicles independent of the fission machinery. These vesicles, falling within the typical size range of MDVs, were selectively loaded with mitochondrial proteins, especially with functional ATP synthase subunits. Intriguingly, these MDVs maintained membrane potential and could generate ATP. Moreover, MDVs could fuse with naïve mitochondria, transferring their ATP generation machinery. Lastly, this study revealed a potential delivery mechanism of ATP-producing vesicles, presenting a promising avenue to rejuvenate ATP-deficient mitochondria. Overall, this study unveils a novel mechanism for inter-organelle communication by vesicles, which is crucial for maintaining cellular homeostasis and could also be important in pathological conditions.</p>","PeriodicalId":73008,"journal":{"name":"Extracellular vesicles and circulating nucleic acids","volume":"5 2","pages":"271-275"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11293460/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delivery of miR-214 via extracellular vesicles downregulates Xbp1 expression and pro-inflammatory cytokine genes in macrophages. 通过细胞外囊泡输送 miR-214 可下调巨噬细胞中 Xbp1 的表达和促炎细胞因子基因。
Pub Date : 2024-06-01 Epub Date: 2024-05-28 DOI: 10.20517/evcna.2023.64
Gonzalo Almanza, Stephen Searles, Maurizio Zanetti

Aim: Tumor-infiltrating macrophages are tumor-promoting and show activation of the unfolded protein response (UPR). The transcription factor X-box binding protein 1 (XBP1) is a conserved element of the UPR. Upon activation, the UPR mediates the transcriptional activation of pro-inflammatory cytokines and immune suppressive factors, hence contributing to immune dysregulation in the tumor microenvironment (TME). miR-214 is a short non-coding miRNA that targets the 3'-UTR of the Xbp1 transcript. Here, we tested a new method to efficiently deliver miR-214 to macrophages as a potential new therapeutic approach.

Methods: We generated miR-214-laden extracellular vesicles (iEV-214) in a murine B cell and demonstrated that iEV-214 were enriched in miR-214 between 1,500 - 2,000 fold relative to control iEVs.

Results: Bone marrow-derived macrophages (BMDM) treated with iEV-214 for 24 h underwent a specific enrichment in miR-214, suggesting transfer of the miR-214 payload from the iEVs to macrophages. iEV-214 treatment of BMDM markedly reduced (> 50%) Xbp1 transcription under endoplasmic reticulum stress conditions compared to controls. Immune-related genes downstream of XBP1s (Il-6, Il-23p19, and Arg1) were also reduced by 69%, 51%, and 34%, respectively.

Conclusions: Together, these data permit to conclude that iEV-214 are an efficient strategy to downregulate the expression of Xbp1 mRNA and downstream genes in macrophages. We propose miRNA-laden iEVs are a new approach to target macrophages and control immune dysregulation in the TME.

目的:肿瘤浸润巨噬细胞具有肿瘤促进作用,并显示出未折叠蛋白反应(UPR)的激活。转录因子 X-box 结合蛋白 1(XBP1)是 UPR 的一个保守要素。激活后,UPR 会介导促炎细胞因子和免疫抑制因子的转录激活,从而导致肿瘤微环境(TME)中的免疫失调。miR-214 是一种短的非编码 miRNA,以 Xbp1 转录本的 3'-UTR 为靶标。在此,我们测试了一种新方法,将 miR-214 有效递送至巨噬细胞,作为一种潜在的新治疗方法:方法:我们在小鼠 B 细胞中生成了富含 miR-214 的细胞外囊泡(iEV-214),并证明 iEV-214 中 miR-214 的含量比对照 iEV 高出 1,500 - 2,000 倍:用iEV-214处理骨髓衍生巨噬细胞(BMDM)24小时后,miR-214发生了特异性富集,表明miR-214有效载荷从iEVs转移到了巨噬细胞。XBP1s 下游的免疫相关基因(Il-6、Il-23p19 和 Arg1)也分别减少了 69%、51% 和 34%:综合这些数据,我们可以得出结论:iEV-214 是下调巨噬细胞中 Xbp1 mRNA 及下游基因表达的有效策略。我们认为,含有 miRNA 的 iEV 是靶向巨噬细胞和控制 TME 中免疫失调的一种新方法。
{"title":"Delivery of miR-214 via extracellular vesicles downregulates <i>Xbp1</i> expression and pro-inflammatory cytokine genes in macrophages.","authors":"Gonzalo Almanza, Stephen Searles, Maurizio Zanetti","doi":"10.20517/evcna.2023.64","DOIUrl":"10.20517/evcna.2023.64","url":null,"abstract":"<p><strong>Aim: </strong>Tumor-infiltrating macrophages are tumor-promoting and show activation of the unfolded protein response (UPR). The transcription factor X-box binding protein 1 (XBP1) is a conserved element of the UPR. Upon activation, the UPR mediates the transcriptional activation of pro-inflammatory cytokines and immune suppressive factors, hence contributing to immune dysregulation in the tumor microenvironment (TME). miR-214 is a short non-coding miRNA that targets the 3'-UTR of the Xbp1 transcript. Here, we tested a new method to efficiently deliver miR-214 to macrophages as a potential new therapeutic approach.</p><p><strong>Methods: </strong>We generated miR-214-laden extracellular vesicles (iEV-214) in a murine B cell and demonstrated that iEV-214 were enriched in miR-214 between 1,500 - 2,000 fold relative to control iEVs.</p><p><strong>Results: </strong>Bone marrow-derived macrophages (BMDM) treated with iEV-214 for 24 h underwent a specific enrichment in miR-214, suggesting transfer of the miR-214 payload from the iEVs to macrophages. iEV-214 treatment of BMDM markedly reduced (> 50%) Xbp1 transcription under endoplasmic reticulum stress conditions compared to controls. Immune-related genes downstream of XBP1s (<i>Il-6</i>, <i>Il-23p19</i>, and <i>Arg1</i>) were also reduced by 69%, 51%, and 34%, respectively.</p><p><strong>Conclusions: </strong>Together, these data permit to conclude that iEV-214 are an efficient strategy to downregulate the expression of <i>Xbp1</i> mRNA and downstream genes in macrophages. We propose miRNA-laden iEVs are a new approach to target macrophages and control immune dysregulation in the TME.</p>","PeriodicalId":73008,"journal":{"name":"Extracellular vesicles and circulating nucleic acids","volume":"5 2","pages":"249-258"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11308798/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141908532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
G protein-coupled receptors: a gateway to targeting oncogenic EVs? G 蛋白偶联受体:靶向致癌 EV 的通道?
Pub Date : 2024-05-23 DOI: 10.20517/evcna.2024.10
Lotte Di Niro, Amber C. Linders, Thomas Glynn, D. M. Pegtel, M. Siderius, C. Crudden, Martine J. Smit
Dysregulated intercellular communication is a key feature driving cancer progression. Recently, extracellular vesicles (EVs) have added a new channel to this dense communication network. Despite solid evidence that EVs are central mediators of dysregulated signaling in onco-pathological settings, this has yet to be translated into clinically actionable strategies. The heterogeneity of EV cargo molecules, plasticity of biogenesis routes, and large overlap with their role in physiological communication, complicate a potential targeting strategy. However, recent work has linked EV biology to perhaps the "most druggable" proteins - G protein-coupled receptors (GPCRs). GPCR targeting accounts for ~60% of drugs in development and more than a third of all currently approved drugs, spanning almost all areas of medicine. Although several GPCRs have been linked to cancer initiation and progression, relatively few agents have made it into oncological regimes, suggesting that their potential is underexploited. Herein, we examine the molecular mechanisms linking GPCRs to EV communication in cancer settings. We propose that GPCRs hold potential in the search for EV-targeting in oncology.
细胞间通讯失调是导致癌症进展的一个关键特征。最近,细胞外囊泡(EVs)为这一密集的通讯网络增添了新的渠道。尽管有确凿证据表明,细胞外囊泡是肿瘤病理环境中信号失调的核心介质,但这尚未转化为临床可操作的策略。EV载货分子的异质性、生物生成途径的可塑性以及与其在生理通讯中的作用的大量重叠,使潜在的靶向策略变得复杂。不过,最近的研究工作已将 EV 生物学与或许是 "最有药用价值 "的蛋白质--G 蛋白偶联受体(GPCR)联系起来。以 GPCR 为靶点的药物约占在研药物的 60%,占目前已批准药物的三分之一以上,几乎涵盖了所有医学领域。虽然有几种 GPCR 与癌症的发生和发展有关,但能用于肿瘤治疗的药物相对较少,这表明它们的潜力尚未得到充分开发。在此,我们研究了癌症环境中连接 GPCR 与 EV 通信的分子机制。我们认为,GPCR 在寻找肿瘤学中的 EV 靶向药物方面具有潜力。
{"title":"G protein-coupled receptors: a gateway to targeting oncogenic EVs?","authors":"Lotte Di Niro, Amber C. Linders, Thomas Glynn, D. M. Pegtel, M. Siderius, C. Crudden, Martine J. Smit","doi":"10.20517/evcna.2024.10","DOIUrl":"https://doi.org/10.20517/evcna.2024.10","url":null,"abstract":"Dysregulated intercellular communication is a key feature driving cancer progression. Recently, extracellular vesicles (EVs) have added a new channel to this dense communication network. Despite solid evidence that EVs are central mediators of dysregulated signaling in onco-pathological settings, this has yet to be translated into clinically actionable strategies. The heterogeneity of EV cargo molecules, plasticity of biogenesis routes, and large overlap with their role in physiological communication, complicate a potential targeting strategy. However, recent work has linked EV biology to perhaps the \"most druggable\" proteins - G protein-coupled receptors (GPCRs). GPCR targeting accounts for ~60% of drugs in development and more than a third of all currently approved drugs, spanning almost all areas of medicine. Although several GPCRs have been linked to cancer initiation and progression, relatively few agents have made it into oncological regimes, suggesting that their potential is underexploited. Herein, we examine the molecular mechanisms linking GPCRs to EV communication in cancer settings. We propose that GPCRs hold potential in the search for EV-targeting in oncology.","PeriodicalId":73008,"journal":{"name":"Extracellular vesicles and circulating nucleic acids","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141105150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Which casein micelle removal method is suitable for studies of human milk extracellular vesicles? A systematic comparison of four different treatments for casein depletion before extracellular vesicle isolation from human milk 哪种酪蛋白胶束去除方法适合人乳细胞外囊泡研究?系统比较从母乳中分离胞外囊泡前的四种不同酪蛋白去除处理方法
Pub Date : 2024-05-22 DOI: 10.20517/evcna.2024.02
Hatice Cetinkaya, Supasek Kongsomros, Laurie Nommsen-Rivers, Ardythe L. Morrow, S. Chutipongtanate
Aim: This study aimed to systematically compare four casein micelle removal methods on the particle and protein characteristics of the isolated human milk EVs. Methods: The defatted milk was treated with 1% sodium citrate, 20 mM ethylenediaminetetraacetic acid (EDTA), 1% acetic acid, or 1% chymosin/calcium chloride for 30 min at 4 °C to remove casein micelles. EV isolation was performed using qEV size exclusion chromatography. Milk turbidity at the optical density 350 nm and dot immunoblot with casein antibody were applied to monitor the qEV fractions. Particle analyses were performed using transmission electron microscopy (TEM) and nanoparticle tracking analysis (NTA). The enrichment of human milk EV markers, i.e., tetraspanins, Alix, lactadherin, butyrophilin, and xanthine dehydrogenase, and casein depletion capabilities were evaluated by proteomics and immunoblotting. Results: Compared to the untreated condition, sodium citrate and EDTA decreased milk turbidity by disrupting casein micelles, while acetic acid and chymosin removed them by inducing precipitation/coagulation. All treatments shifted casein immunoreactivity in the qEV fractions from large micelles (the exclusion volume) to small molecular sizes (gel-infiltrated fractions). Acidification affected human milk EV morphology, while EDTA, acetic acid, and chymosin methods slightly altered EV particle numbers. Different casein micelle removal methods confer different degrees of human milk EV marker enrichment and casein depletion. The method performances could be ranked as follows: chymosin > EDTA > acetic acid > sodium citrate. Conclusion: Our findings suggest that chymosin and EDTA should be considered as the method of choice for casein micelle removal in future studies involving human milk EV isolation and characterization.
目的:本研究旨在系统比较四种酪蛋白胶束去除方法对分离出的人乳EVs的颗粒和蛋白质特征的影响。方法:将脱脂牛奶用 1%柠檬酸钠、20 mM 乙二胺四乙酸处理:脱脂牛奶经1%柠檬酸钠、20 mM乙二胺四乙酸(EDTA)、1%醋酸或1%糜蛋白酶/氯化钙在4 ℃下处理30分钟,以去除酪蛋白胶束。使用 qEV 排阻色谱法分离 EV。用光密度为 350 nm 的牛奶浑浊度和酪蛋白抗体点免疫印迹来监测 qEV 产物。利用透射电子显微镜(TEM)和纳米粒子跟踪分析(NTA)对粒子进行分析。通过蛋白质组学和免疫印迹法评估了人乳 EV 标记(即四泛蛋白、Alix、乳粘连蛋白、丁淀粉蛋白和黄嘌呤脱氢酶)的富集和酪蛋白耗竭能力。结果与未处理的情况相比,柠檬酸钠和乙二胺四乙酸通过破坏酪蛋白胶束来降低牛奶的浑浊度,而醋酸和糜蛋白酶则通过诱导沉淀/凝固来去除酪蛋白胶束。所有处理方法都会使qEV馏分中的酪蛋白免疫反应从大胶束(排除体积)转移到小分子大小(凝胶渗透馏分)。酸化会影响人乳EV的形态,而乙二胺四乙酸、醋酸和糜蛋白酶方法会轻微改变EV颗粒的数量。不同的酪蛋白胶束去除方法对人乳 EV 标记富集和酪蛋白耗竭的程度不同。不同方法的性能排名如下:糜蛋白酶 > EDTA > 乙酸 > 柠檬酸钠。结论我们的研究结果表明,在今后涉及人乳 EV 分离和表征的研究中,糜蛋白酶和 EDTA 应被视为去除酪蛋白胶束的首选方法。
{"title":"Which casein micelle removal method is suitable for studies of human milk extracellular vesicles? A systematic comparison of four different treatments for casein depletion before extracellular vesicle isolation from human milk","authors":"Hatice Cetinkaya, Supasek Kongsomros, Laurie Nommsen-Rivers, Ardythe L. Morrow, S. Chutipongtanate","doi":"10.20517/evcna.2024.02","DOIUrl":"https://doi.org/10.20517/evcna.2024.02","url":null,"abstract":"Aim: This study aimed to systematically compare four casein micelle removal methods on the particle and protein characteristics of the isolated human milk EVs.\u0000 Methods: The defatted milk was treated with 1% sodium citrate, 20 mM ethylenediaminetetraacetic acid (EDTA), 1% acetic acid, or 1% chymosin/calcium chloride for 30 min at 4 °C to remove casein micelles. EV isolation was performed using qEV size exclusion chromatography. Milk turbidity at the optical density 350 nm and dot immunoblot with casein antibody were applied to monitor the qEV fractions. Particle analyses were performed using transmission electron microscopy (TEM) and nanoparticle tracking analysis (NTA). The enrichment of human milk EV markers, i.e., tetraspanins, Alix, lactadherin, butyrophilin, and xanthine dehydrogenase, and casein depletion capabilities were evaluated by proteomics and immunoblotting.\u0000 Results: Compared to the untreated condition, sodium citrate and EDTA decreased milk turbidity by disrupting casein micelles, while acetic acid and chymosin removed them by inducing precipitation/coagulation. All treatments shifted casein immunoreactivity in the qEV fractions from large micelles (the exclusion volume) to small molecular sizes (gel-infiltrated fractions). Acidification affected human milk EV morphology, while EDTA, acetic acid, and chymosin methods slightly altered EV particle numbers. Different casein micelle removal methods confer different degrees of human milk EV marker enrichment and casein depletion. The method performances could be ranked as follows: chymosin > EDTA > acetic acid > sodium citrate.\u0000 Conclusion: Our findings suggest that chymosin and EDTA should be considered as the method of choice for casein micelle removal in future studies involving human milk EV isolation and characterization.","PeriodicalId":73008,"journal":{"name":"Extracellular vesicles and circulating nucleic acids","volume":"17 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141112638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hollow fiber bioreactor allows sustained production of immortalized mesenchymal stromal cell-derived extracellular vesicles 中空纤维生物反应器可持续生产永生化间充质基质细胞衍生的细胞外囊泡
Pub Date : 2024-05-14 DOI: 10.20517/evcna.2023.76
Sergio G Garcia, Marta Sanroque-Muñoz, Marta Clos-Sansalvador, Miriam Font-Morón, M. Monguió-Tortajada, F. Borràs, Marcella Franquesa
Aim: Mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs) have been reported to hold great potential as cell-free therapies due to their low immunogenicity and minimal toxicity. However, the large doses of MSC-EVs that are required for their clinical application highlight the urgency of finding a large-scale system for MSC-EV manufacture. In this study, we aimed to set up a hollow fiber bioreactor system for the continuous homogenous production of functional and high-quality MSC-EVs. Methods: MSC lines from two donors were immortalized (iMSC) and inoculated into hollow fiber bioreactors. Throughout 4 weeks, conditioned medium was daily harvested. iMSC-EVs were purified and characterized for content, immunophenotype, size, and functionality and compared to 2D cultured iMSC. Results: The iMSC inoculated into the bioreactor remained viable during the whole culture period, and they maintained their MSC phenotype at the end of EV production. Our results showed that the bioreactor system allows to obtain 3D-cultured iMSC-derived EVs (3D-EVs) that are comparable to flask (2D)-cultured iMSC-derived EVs (2D-EVs) in terms of protein and lipid content, size, and phenotype. We also confirm that 3D-derived EVs exhibit comparable functionality to 2D-EVs, showing pro-angiogenic potential in a dose-dependent manner. Conclusions: These findings suggest that setting up a hollow fiber bioreactor system inoculating immortalized MSC lines facilitates the large-scale, functional, and high-quality production of iMSC-EVs. Our results emphasize the great potential of this production methodology to standardize EV production in the pursuit of clinical applications.
目的:据报道,间充质基质细胞衍生的细胞外囊泡(MSC-EVs)因其免疫原性低、毒性小而具有作为无细胞疗法的巨大潜力。然而,其临床应用所需的大剂量间充质干细胞-细胞外小泡突显了寻找大规模间充质干细胞-细胞外小泡制造系统的紧迫性。在本研究中,我们旨在建立一个中空纤维生物反应器系统,用于连续均质生产功能性和高质量间充质干细胞-EV。方法将两名供体的间充质干细胞系永生化(iMSC)并接种到中空纤维生物反应器中。对 iMSC-EV 进行纯化,对其含量、免疫表型、大小和功能进行鉴定,并与二维培养的 iMSC 进行比较。结果接种到生物反应器中的 iMSC 在整个培养期间保持存活,并且在 EV 生产结束时仍保持间充质干细胞的表型。我们的结果表明,生物反应器系统可以获得三维培养的 iMSC 衍生 EV(三维-EV),其蛋白质和脂质含量、大小和表型与烧瓶(2D)培养的 iMSC 衍生 EV(2D-EV)相当。我们还证实,三维衍生的 EVs 具有与二维 EVs 相当的功能,并以剂量依赖的方式显示出促进血管生成的潜力。结论这些研究结果表明,建立中空纤维生物反应器系统接种永生化间叶干细胞系有助于大规模、功能性和高质量地生产 iMSC-EV。我们的研究结果表明,这种生产方法在实现 EV 生产标准化、促进临床应用方面具有巨大潜力。
{"title":"Hollow fiber bioreactor allows sustained production of immortalized mesenchymal stromal cell-derived extracellular vesicles","authors":"Sergio G Garcia, Marta Sanroque-Muñoz, Marta Clos-Sansalvador, Miriam Font-Morón, M. Monguió-Tortajada, F. Borràs, Marcella Franquesa","doi":"10.20517/evcna.2023.76","DOIUrl":"https://doi.org/10.20517/evcna.2023.76","url":null,"abstract":"Aim: Mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs) have been reported to hold great potential as cell-free therapies due to their low immunogenicity and minimal toxicity. However, the large doses of MSC-EVs that are required for their clinical application highlight the urgency of finding a large-scale system for MSC-EV manufacture. In this study, we aimed to set up a hollow fiber bioreactor system for the continuous homogenous production of functional and high-quality MSC-EVs.\u0000 Methods: MSC lines from two donors were immortalized (iMSC) and inoculated into hollow fiber bioreactors. Throughout 4 weeks, conditioned medium was daily harvested. iMSC-EVs were purified and characterized for content, immunophenotype, size, and functionality and compared to 2D cultured iMSC.\u0000 Results: The iMSC inoculated into the bioreactor remained viable during the whole culture period, and they maintained their MSC phenotype at the end of EV production. Our results showed that the bioreactor system allows to obtain 3D-cultured iMSC-derived EVs (3D-EVs) that are comparable to flask (2D)-cultured iMSC-derived EVs (2D-EVs) in terms of protein and lipid content, size, and phenotype. We also confirm that 3D-derived EVs exhibit comparable functionality to 2D-EVs, showing pro-angiogenic potential in a dose-dependent manner.\u0000 Conclusions: These findings suggest that setting up a hollow fiber bioreactor system inoculating immortalized MSC lines facilitates the large-scale, functional, and high-quality production of iMSC-EVs. Our results emphasize the great potential of this production methodology to standardize EV production in the pursuit of clinical applications.","PeriodicalId":73008,"journal":{"name":"Extracellular vesicles and circulating nucleic acids","volume":"51 14","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140980791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Extracellular vesicles and circulating nucleic acids
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1